2.4.0.84090 - Disclosure - Commitments and Contingencies (Details)truefalseIn Millions, unless otherwise specifiedfalse1false USDfalsefalse$D2013Q1_M0131http://www.sec.gov/CIK0001264587duration2013-01-30T00:00:002013-01-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDtruefalse$D2013Q2YTD_ResearchAndDevelopmentAgreementsWithThirdPartiesMemberhttp://www.sec.gov/CIK0001264587duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseResearch and development agreements with third partiesus-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxisxbrldihttp://xbrl.org/2006/xbrldistml_ResearchAndDevelopmentAgreementsWithThirdPartiesMemberus-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDtruefalse$I2013Q1_M0228_BioprocessingServicesAgreementMemberhttp://www.sec.gov/CIK0001264587instant2013-02-28T00:00:000001-01-01T00:00:00falsefalseBioprocessing services agreementus-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxisxbrldihttp://xbrl.org/2006/xbrldistml_BioprocessingServicesAgreementMemberus-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0License Agreements2false 4stml_CollaborativeArrangementPaymentsRequiredToBeMadeUponAchievementOfMilestonesstml_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse2900000029.0USD$falsetruefalse3falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents the payments required to be made upon achievement of certain milestones under the collaborative arrangement.No definition available.false2Amount required to be paid upon achievement of certain milestones3false 4stml_CollaborativeArrangementAmountPaidOrAccruedUponAchievementOfMilestonesInceptionToDatestml_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse17000001.7falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents the amount paid or accrued as of the balance sheet date since inception, upon achievement of certain milestones under the collaborative arrangements.No definition available.false2Amount paid or accrued from inception to date, resulting from the execution of certain agreements, patent approvals, the initiation of sponsor research agreements, and compound development agreements4true 4stml_ContractualAgreementAbstractstml_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Contractual Agreement5false 5us-gaap_ContractualObligationus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse29000002.9falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.No definition available.false2Contractual agreement value6true 2stml_CompensationArrangementsAbstractstml_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Compensation Arrangements7false 3stml_PaymentOfIPOCompensationExpensestml_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse10000001.0falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow associated with compensation expense related to certain bonuses and salary increases payable upon continued employment and the occurrence of a specified financing, including the consummation of an initial public offering.No definition available.false2Bonuses and salary increases paid upon the closing of the IPO8false 3stml_IPOCompensationExpensePayableCurrentstml_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse4000000.4USD$falsetruefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of compensation expense payable within one year related to certain bonuses and salary increases payable upon continued employment and the occurrence of a specified financing, including the consummation of an initial public offering.No definition available.false2Bonuses and salary increases payable upon the closing of the IPOfalseCommitments and Contingencies (Details) (USD $)HundredThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.stemline.com/role/DisclosureCommitmentsAndContingenciesDetails38